The Ministry of Health of Ukraine has registered a COVID-19 vaccine developed by Oxford University and the British-Swedish company AstraZeneca. The drug was approved for emergency medical use on Monday, February 22nd.
“The Oxford / AstraZeneca vaccine produced at the facilities of the Serum Institute (India) has a local (trade) name Covishield. Accordingly, the Covishield vaccine, which is arriving in Ukraine today, is officially registered, ”the Ukrainian Ministry of Health said. According to COVAX, delivery of 2.2 million to 3.7 million doses is expected in the first-second quarter of 2021. The vaccine will be purchased for public funds directly from manufacturers.
In early February, the Prime Minister of Ukraine Denis Shmyhal signed a decree banning the registration of Russian vaccines against coronavirus in the country. In the corresponding document, Russia is called an “aggressor country”. Prior to that, Ukrainian President Volodymyr Zelensky said that Ukrainians are not rabbits to test the Russian Sputnik V vaccine on them.
As of February 23, 4182 new confirmed cases of coronavirus were recorded in Ukraine. The number of active patients is 134,758.
Kommersant’s map: to what extent and how the world is vaccinated against COVID-19
Read more
#Oxford #AstraZeneca #vaccine #COVID19 #registered #Ukraine
